Accendra Health, Inc.

ACH — fair value pending

NYSE · Healthcare

FAIR PRICE

Not availablefor ACH at this time

Our blended valuation model could not produce a fair price for Accendra Health, Inc. right now. This usually happens when financial data is incomplete, the company recently went public, or it operates in a sector where standard valuation methods don't apply (e.g. early-stage biotech, REITs, or specialty financials). We re-run the model daily — check back soon.

$0.21

MARKET PRICE

Pending

FAIR PRICE

COMMUNITY BUY ZONE

UNLOCKS AT 10

Where does the market buy ACH?

No one has priced ACH yet — be the first. Every investor sets the maximum price they'd still buy at; together that maps the community buy zone.

COMMUNITY MEDIAN

▓▓▓▓▓

BUYERS AT TODAY'S PRICE

▓▓ %

0/10 INVESTORS · 10 MORE TO UNLOCK

METRICS

P/E–
P/B–
P/S0.0
PEG–
DIV YIELD–
ROE–
ROIC6.4%
DEBT/EQ–
FCF YIELD-1325.4%
MKT CAP$17M

NOW AVAILABLE

Track ACH in the Fair Price Index app

Add ACH to your watchlist and we'll notify you the moment a fair price becomes available.

Download on the App StoreGet it on Google Play

METHODOLOGY

How we calculate fair price

Our fair price is derived from a blended model that combines DCF analysis (50%), relative valuation against sector peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). For ACH the model could not produce a result this run — typically due to incomplete financial data or a sector where standard valuation methods don't apply. Learn more about how fair value works.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting ACH's risk profile.

RELATIVE · 30%

Comparing ACH's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for ACH, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate ACH's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for ACH.

Explore on Bulios

FAQ

Why is there no fair price for ACH?+

Our blended valuation model could not produce a fair price for Accendra Health, Inc. at this time. This usually happens when financial data is incomplete, the company recently went public, or it operates in a sector where standard valuation methods (DCF, P/E multiples, EV/EBITDA) don't apply well — for example early-stage biotech, REITs, or specialty financials. We re-run the model daily, so check back soon.

What is ACH's current market price?+

Accendra Health, Inc. (ACH) currently trades at $0.21. Market price is provided by our data partner and updated daily.

Will ACH get a fair price calculation later?+

Yes — we re-run the valuation model daily. As soon as the underlying financial data is sufficient and the model converges, ACH's fair price will appear here automatically. You can also add ACH to your watchlist in the Fair Price Index app and we'll notify you when a fair price becomes available.

What metrics are available for ACH?+

For ACH we currently have limited financial data — most key metrics are not yet available. Sector classification: Healthcare.

How does Fair Price Index calculate fair value?+

Our blended model combines three approaches: discounted cash flow analysis (50% weight), relative valuation against sector peers using P/E and EV/EBITDA multiples (30% weight), and aggregated Wall Street analyst consensus (20% weight). When any of these inputs is missing or unreliable, the model abstains rather than producing a misleading number.

Can I estimate ACH's fair value myself?+

Yes. You can use our DCF Calculator and Graham Number Calculator (linked above) to plug in your own assumptions and produce an independent estimate. These calculators are free and don't require a fair price from our model to work.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.